These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26606442)

  • 1. Early in vivo discrimination of vulnerable atherosclerotic plaques that disrupt: A serial MRI study.
    Pham TA; Hua N; Phinikaridou A; Killiany R; Hamilton J
    Atherosclerosis; 2016 Jan; 244():101-7. PubMed ID: 26606442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging features of vulnerable plaques in an atherosclerotic rabbit model.
    Zhao XC; Zhao QM; Ma XH; Zeng CH; Feng TT; Zhao X; Zhang ZQ; Zhang MD; Zhuang XC
    Chin Med J (Engl); 2013; 126(11):2163-7. PubMed ID: 23769577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo detection of vulnerable atherosclerotic plaque by MRI in a rabbit model.
    Phinikaridou A; Ruberg FL; Hallock KJ; Qiao Y; Hua N; Viereck J; Hamilton JA
    Circ Cardiovasc Imaging; 2010 May; 3(3):323-32. PubMed ID: 20194634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regions of low endothelial shear stress colocalize with positive vascular remodeling and atherosclerotic plaque disruption: an in vivo magnetic resonance imaging study.
    Phinikaridou A; Hua N; Pham T; Hamilton JA
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):302-10. PubMed ID: 23357244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictors of vulnerable atherosclerotic plaques induced by cholesterol and balloon injury in rabbits].
    Yin Y; Li Y; Ji XP; Zhang Y; Chen WQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):343-7. PubMed ID: 21624311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
    Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
    PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular remodeling and plaque vulnerability in a rabbit model of atherosclerosis: comparison of delayed-enhancement MR imaging with an elastin-specific contrast agent and unenhanced black-blood MR imaging.
    Phinikaridou A; Andia ME; Indermuehle A; Onthank DC; Cesati RR; Smith A; Robinson SP; Saha P; Botnar RM
    Radiology; 2014 May; 271(2):390-9. PubMed ID: 24475852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of High-Risk Plaques by MRI and Fluorescence Imaging in a Rabbit Model of Atherothrombosis.
    Hua N; Baik F; Pham T; Phinikaridou A; Giordano N; Friedman B; Whitney M; Nguyen QT; Tsien RY; Hamilton JA
    PLoS One; 2015; 10(10):e0139833. PubMed ID: 26448434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of atherosclerotic plaque progression in the abdominal aorta of rabbits with 3T magnetic resonance imaging.
    Ma XH; Zhao L; Zhao QM; Feng TT; Shang JF; Zhang ZQ
    Chin Med J (Engl); 2012 Aug; 125(15):2714-8. PubMed ID: 22931980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatio-temporal texture (SpTeT) for distinguishing vulnerable from stable atherosclerotic plaque on dynamic contrast enhancement (DCE) MRI in a rabbit model.
    Wan T; Madabhushi A; Phinikaridou A; Hamilton JA; Hua N; Pham T; Danagoulian J; Kleiman R; Buckler AJ
    Med Phys; 2014 Apr; 41(4):042303. PubMed ID: 24694153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Vascular Permeability Measured With an Albumin-Binding Magnetic Resonance Contrast Agent Is a Surrogate Marker of Rupture-Prone Atherosclerotic Plaque.
    Phinikaridou A; Andia ME; Lavin B; Smith A; Saha P; Botnar RM
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of lipid-rich aortic plaques by intravascular photoacoustic tomography: ex vivo and in vivo validation in a rabbit atherosclerosis model with histologic correlation.
    Zhang J; Yang S; Ji X; Zhou Q; Xing D
    J Am Coll Cardiol; 2014 Jul; 64(4):385-90. PubMed ID: 25060374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI of atherosclerosis and fatty liver disease in cholesterol fed rabbits.
    Taylor E; Huang N; Bodde J; Ellison A; Killiany R; Bachschmid MM; Hamilton J
    J Transl Med; 2018 Aug; 16(1):215. PubMed ID: 30068362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model.
    Abela GS; Picon PD; Friedl SE; Gebara OC; Miyamoto A; Federman M; Tofler GH; Muller JE
    Circulation; 1995 Feb; 91(3):776-84. PubMed ID: 7828306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo MR imaging of plaque disruption and thrombus formation in an atherosclerotic rabbit model.
    Ma X; Zhao Q; Zhao L; Shang J; Feng T; Zeng C; Zhang Z
    Int J Cardiovasc Imaging; 2012 Mar; 28(3):577-86. PubMed ID: 21461662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
    Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Vulnerable Atherosclerotic Plaques in Experimental Atherosclerosis with the USPIO-Enhanced MRI.
    Qi CM; Du L; Wu WH; Li DY; Hao J; Gong L; Deng L; Zhang T; Zhang C; Zhang Y
    Cell Biochem Biophys; 2015 Nov; 73(2):331-337. PubMed ID: 27352319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI study of atherosclerotic plaque progression using ultrasmall superparamagnetic iron oxide in Watanabe heritable hyperlipidemic rabbits.
    Kaneko C; Nitta N; Tsuchiya K; Watanabe S; Nitta-Seko A; Ohta S; Otani H; Sonoda A; Murata K; Shiomi M
    Br J Radiol; 2015 Sep; 88(1053):20150167. PubMed ID: 26083261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
    Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
    Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiatherosclerotic effects of the novel angiotensin receptor antagonist Fimasartan on plaque progression and stability in a rabbit model: a double-blind placebo-controlled trial.
    Lee JY; Lee CW; Kim WJ; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Son WC; Jung S; Park SW; Park SJ
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):229-36. PubMed ID: 23615162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.